Get started
Author

Philippe Stas

Observed name: P. Stas
OpenAlex ID: A5069115228
Taking immunogenicity assessment of therapeutic proteins to the next level
2011 · I.C. Büttel, P. Chamberlain, et al. · Biologicals · 140
Immunogenicity screening in protein drug development
2007 · Ivo Van Walle, Yannick Gansemans, et al. · Expert Opinion on Biological Therapy · 87
Conduction disorder and QT prolongation secondary to long-term treatment with chloroquine
2007 · Philippe Stas, Dirk Faes, et al. · International Journal of Cardiology · 72
Preclinical Models Used for Immunogenicity Prediction of Therapeutic Proteins
2013 · Vera Brinks, Daniel Weinbuch, et al. · Pharmaceutical Research · 60
Strategies for preclinical immunogenicity assessment of protein therapeutics.
2009 · Philippe Stas, Ignace Lasters · PubMed · 26
Immunogénicité de protéines d’intérêt thérapeutique
2009 · Philippe Stas, Ignace Lasters, et al. · médecine/sciences · 15
PDF
The TNFα-binding domain of the therapeutic antibody adalimumab elicits CD4 T-cell responses in rheumatoid arthritis patients
2025 · Mateusz Makuch, Josine van Beek, et al. · Frontiers in Immunology · 3
PDF
Immunogenicity Assessment of Antibody Therapeutics
2009 · Philippe Stas, Jurgen Pletinckx, et al. · Cambridge University Press eBooks · 2
Immunogenicity Assessment of Antibody Therapeutics
2009 · P. Stas, Y. Gansemans, et al. · Springer eBooks · 1
Immunogenicity of a CXCL8-based biopharmaceutical drug candidate in comparison to its wildtype form
2025 · Elisa Talker, Tanja Gerlza, et al. · Frontiers in Immunology
PDF
Works count: 10
Citation count: 406
H-index: 6
I10-index: 6
Year
Topic
Type